Genome-Wide Profiling Reveals the Landscape of Prognostic Alternative Splicing Signatures in Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive lethal malignancy. Identification of potential alternative splicing (AS) prognostic indicators and related splicing pathways for the prediction of PDAC outcomes is lacking but urgently needed. A combined strategy of prognostic assessment and c...
Main Authors: | Chengkun Yang, Qiongyuan Wu, Ketuan Huang, Xiangkun Wang, Tingdong Yu, Xiwen Liao, Jianlu Huang, Guangzhi Zhu, Yizhen Gong, Chuangye Han, Hao Su, Wei Qin, Tao Peng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.00511/full |
Similar Items
-
Interrelationship between miRNA and splicing factors in pancreatic ductal adenocarcinoma
by: I Gede Putu Supadmanaba, et al.
Published: (2022-04-01) -
Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential
by: Emilia Alors-Pérez, et al.
Published: (2023-10-01) -
Genome-Wide Analysis of Prognostic Alternative Splicing Signature and Splicing Factors in Lung Adenocarcinoma
by: Ya-Sian Chang, et al.
Published: (2020-10-01) -
First-in-Class Humanized Antibody against Alternatively Spliced Tissue Factor Augments Anti-Metastatic Efficacy of Chemotherapy in a Preclinical Model of Pancreatic Ductal Adenocarcinoma
by: Clayton S. Lewis, et al.
Published: (2024-02-01) -
Identification of prognostic alternative splicing signature in gastric cancer
by: Zhiwu Wang, et al.
Published: (2022-05-01)